Truqap

capivasertib

Approval

ApplicationNDA 218197
Approval dateNov 16, 2023
Approval year2023
SponsorAstrazeneca

FDA-approved use

To treat breast cancer that meets certain disease criteria

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Truqap: